DaVita HealthCare (DVA) stock declines slightly, outperforming the Medical sector, with analyst forecasts uncertain.

From Nasdaq: 2025-04-17 18:15:00

DaVita HealthCare (DVA) closed at $140.03, down 1.04% from the previous session, trailing the S&P 500’s 0.13% gain. The company’s shares lost 5.56% in the past month, narrower than the Medical sector’s 8.46% loss. DaVita is expected to report an EPS of $1.75 and revenue of $3.23 billion.

Analysts forecast DaVita’s EPS to decrease by 26.47% year-over-year, with revenue growing by 5.27%. The Zacks Consensus Estimates predict earnings of $10.76 per share and revenue of $13.47 billion for the fiscal year. Recent analyst estimates directly impact stock prices, with DaVita currently holding a Zacks Rank #4 (Sell).

DaVita HealthCare is trading at a Forward P/E ratio of 13.15, below the industry average of 20.35. With a PEG ratio of 1.04, DaVita’s expected earnings growth is favorable. The Medical – Outpatient and Home Healthcare industry, where DaVita belongs, has a Zacks Industry Rank of 31, placing it in the top 13% among all industries.



Read more at Nasdaq: DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors